 |
|
Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
Jung Gil Park
Clin Mol Hepatol. 2015;21(3):287-294. Published online 2015 Sep 30 DOI: https://doi.org/10.3350/cmh.2015.21.3.287
|
|
Citations to this article as recorded by
 Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy
Rui Feng, De-Xin Cheng, Tao Song, Long Chen, Kai-Ping Lu
World Journal of Gastrointestinal Surgery.2023; 15(4): 687. CrossRef Long-term follow-up of complete remission in a patient with advanced hepatocellular carcinoma treated with sorafenib: a case report
Gordan Adžić, Juraj Prejac, Stjepko Pleština
Frontiers in Oncology.2023;[Epub] CrossRef Long-term survival with sorafenib-based multidisciplinary treatment for Vp4 hepatocellular carcinoma: a case report
Hibiki Narita, Hideto Kawaratani, Akihiko Shibamoto, Soichi Takeda, Takahiro Ozutsumi, Yuki Tsuji, Yukihisa Fujinaga, Koh Kitagawa, Norihisa Nishimura, Daisuke Hokuto, Masayuki Sho, Hitoshi Yoshiji
Clinical Journal of Gastroenterology.2022; 15(5): 953. CrossRef Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis
Hai-Yi Long, Tong-Yi Huang, Xiao-Yan Xie, Jian-Ting Long, Bao-Xian Liu
World Journal of Clinical Cases.2021; 9(21): 5754. CrossRef Identification of the Response-Related Biomarker of Bimonthly Hepatic Arterial Infusion Chemotherapy
Kei Moriya, Tadashi Namisaki, Hiroaki Takaya, Kosuke Kaji, Hideto Kawaratani, Naotaka Shimozato, Yasuhiko Sawada, Akitoshi Douhara, Shinya Sato, Masanori Furukawa, Koh Kitagawa, Takemi Akahane, Hitoshi Yoshiji
Journal of Clinical Medicine.2021; 10(4): 629. CrossRef Long-term complete response to lenvatinib in a patient with unresectable hepatocellular carcinoma
Morihiko Ishizaki, Masaki Kaibori, Hideyuki Matsushima, Hisashi Kosaka, Kosuke Matsui, Mitsugu Sekimoto
Clinical Journal of Gastroenterology.2021; 14(6): 1700. CrossRef Sorafenib treatment has the potential to downstage advanced hepatocellular carcinoma before liver resection
Alessandra Bertacco, Alessandro Vitale, Claudia Mescoli, Umberto Cillo
Personalized Medicine.2020; 17(2): 83. CrossRef Long-term sustained complete response with off-therapy to sorafenib in advanced hepatocellular carcinoma: a case report
Takeshi Koujima, Yoshikatsu Endo, Takeharu Yamamoto, Toshifumi Tada, Kazuhiko Morii, Shinichiro Nakamura, Kyohei Kai
Kanzo.2020; 61(5): 255. CrossRef Effectiveness of sorafenib dose modifications on treatment outcome of hepatocellular carcinoma: Analysis in real‐life settings
Kwon Yong Tak, Hee Chul Nam, Jong Young Choi, Seung Kew Yoon, Chang Wook Kim, Hee Yeon Kim, Sung Won Lee, Hae Lim Lee, U Im Chang, Do Seon Song, Jin Mo Yang, Jung Hyun Kwon, Sun Hong Yoo, Pil Soo Sung, Sang Wook Choi, Myeong Jun Song, Seok Hwan Kim, Jeong
International Journal of Cancer.2020; 147(7): 1970. CrossRef Sequential bilateral PVTT successfully controlled by radiotherapy and sorafenib, respectively
Yung‐Ning Huang, Yang‐Bor Lu, Sheng‐Nan Lu
The Kaohsiung Journal of Medical Sciences.2019; 35(1): 63. CrossRef Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling
Zhang-Bin Tan, Hui-Jie Fan, Yu-Ting Wu, Ling-Peng Xie, Yi-Ming Bi, Hong-Lin Xu, Hong-Mei Chen, Jun Li, Bin Liu, Ying-Chun Zhou
Journal of Ethnopharmacology.2019; 232: 62. CrossRef Liver Transplantation after Successful Downstaging with Hepatic Arterial Infusion Chemotherapy in a Patient with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Hee Chul Nam, Pil Soo Sung, Ho Jong Chun, Dong Goo Kim, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon
Journal of Liver Cancer.2019; 19(1): 64. CrossRef Antineoplastic properties of zafirlukast against hepatocellular carcinoma via activation of mitochondrial mediated apoptosis
Pranesh Kumar, Aakriti Agarwal, Ashok K. Singh, Anurag Kumar Gautam, Sreemoyee Chakraborti, Umesh Kumar, Dinesh Kumar, Bolay Bhattacharya, Parthasarathi Panda, Biswajit Saha, Tabish Qidwai, Biswanath Maity, Sudipta Saha
Regulatory Toxicology and Pharmacology.2019; 109: 104489. CrossRef Complete Response Using Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma with Multiple Lymph Node and Bone Metastases: A Case Report
Norihiro NOMURA, Takayoshi ITO, Hiroki SHINOHARA, Nobukazu SHIMA, Masashi SATOU, Dai SAKUMA, Junichi EGUCHI, Naoyuki URAGAMI, Yoshio DEGUCHI, Noboru YOKOYAMA, Haruhiro INOUE
The Showa University Journal of Medical Sciences.2019; 31(4): 373. CrossRef Novel fused oxazepino-indoles (FOIs) attenuate liver carcinogenesis via IL-6/JAK2/STAT3 signaling blockade as evidenced through data-based mathematical modeling
Ashok K. Singh, Archana Singh Bhadauria, Umesh Kumar, Vinit Raj, Vimal Maurya, Dinesh Kumar, Biswanath Maity, Anand Prakash, Arnab De, Amalesh Samanta, Sudipta Saha
Life Sciences.2018; 201: 161. CrossRef Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy
Hyerim Byeon, Seung Duk Lee, Eun-Kyung Hong, Dong Eun Lee, Bo Hyun Kim, Yunsung Seo, Jungnam Joo, Sung-Sik Han, Seong Hoon Kim, Sang-Jae Park
Pathology - Research and Practice.2018; 214(6): 814. CrossRef Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer
Sarah Yoon, Eun-Ju Lee, Ji-Hye Choi, Taek Chung, Do Young Kim, Jong-Yeop Im, Myung-Ho Bae, Jung-Hee Kwon, Hyuk-Hoon Kim, Hyung Chul Kim, Young Nyun Park, Hee-Jung Wang, Hyun Goo Woo
Oncogene.2018; 37(32): 4443. CrossRef Novel Indole-fused benzo-oxazepines (IFBOs) inhibit invasion of hepatocellular carcinoma by targeting IL-6 mediated JAK2/STAT3 oncogenic signals
Ashok K. Singh, Archana S. Bhadauria, Umesh Kumar, Vinit Raj, Amit Rai, Pranesh Kumar, Amit K. Keshari, Dinesh Kumar, Biswanath Maity, Sneha Nath, Anand Prakash, Sudipta Saha
Scientific Reports.2018;[Epub] CrossRef Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jong Hwan Choi, Woo Jin Chung, Si Hyun Bae, Do Seon Song, Myeong Jun Song, Young Seok Kim, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Jun Yong Park, Do Young Kim, Seung Up Kim, Sung Bum Cho
Cancer Chemotherapy and Pharmacology.2018; 82(3): 469. CrossRef Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?
Matthias Pinter, Wolfgang Sieghart
memo - Magazine of European Medical Oncology.2018; 11(3): 185. CrossRef Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury
Sofie Martens, Manhyung Jeong, Wulf Tonnus, Friederike Feldmann, Sam Hofmans, Vera Goossens, Nozomi Takahashi, Jan Hinrich Bräsen, Eun-Woo Lee, Pieter Van der Veken, Jurgen Joossens, Koen Augustyns, Simone Fulda, Andreas Linkermann, Jaewhan Song, Peter Va
Cell Death & Disease.2017; 8(6): e2904. CrossRef Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation
Hye Won Lee, Hyun Soo Kim, Seung Up Kim, Do Young Kim, Beom Kyung Kim, Jun Yong Park, Sang Hoon Ahn, Mi Young Jeon, Ja Yoon Heo, Soo Young Park, Yu Rim Lee, Sun Kyung Jang, Su Hyun Lee, Se Young Jang, Won Young Tak, Kwang-Hyub Han
Gut and Liver.2017; 11(5): 693. CrossRef Long-term follow-up of complete remission of advanced hepatocellular carcinoma following sorafenib therapy: A case report
Jung Gil Park, Won Young Tak, Soo Young Park, Young Oh Kweon, Se Young Jang, Soo Hyun Lee, Yu Rim Lee, Sun Kyung Jang, Keun Hur, Heon Ju Lee
Oncology Letters.2017; 14(4): 4853. CrossRef Outcomes of metastatic spinal cord compression secondary to primary hepatocellular carcinoma with multidisciplinary treatments
Shaohui He, Haifeng Wei, Yifei Ma, Jian Zhao, Wei Xu, Jianru Xiao
Oncotarget.2017; 8(26): 43439. CrossRef 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling
Seulki Lee, Minjong Lee, Jong Bin Kim, Ara Jo, Eun Ju Cho, Su Jong Yu, Jeong-Hoon Lee, Jung-Hwan Yoon, Yoon Jun Kim
Biochemical and Biophysical Research Communications.2016; 473(4): 1247. CrossRef Sorafenib
Reactions Weekly.2016; 1599(1): 202. CrossRef Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells
Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Chung Yong Kim, Jung-Hwan Yoon
Biomedicine & Pharmacotherapy.2016; 83: 607. CrossRef Plasma Level of Interleukin-35 as an Independent Prognostic Indicator in Hepatocellular Carcinoma
Xiangting Qiu, Xinhua Wang, Yucui Song, Lingling Chen
Digestive Diseases and Sciences.2016; 61(12): 3513. CrossRef
|